Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Man In 'T Veld

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Blood Pressure. Supplement|January 1, 1997
Surrogate end points in clinical trialsA J Man in 't Veld
American Heart Journal|December 1, 1990
How to select a drug for the long-term treatment of chronic heart failureA J Man in 't Veld
The American Journal of Cardiology|April 22, 1991
Vasodilation, not cardiodepression, underlies the antihypertensive effect of beta-adrenoceptor antagonistsA J Man in 't Veld
Nederlands Tijdschrift Voor Geneeskunde|November 19, 1983
[Recommendations concerning hypertension by the Public Health Council]A J Man in 't Veld
European Heart Journal|June 1, 1992
Clinical pharmacology, efficacy and safety of a new alpha 1 adrenoceptor antagonist with an additional central action, in hypertensionA J Man in 't Veld
The American Journal of Cardiology|May 15, 1987
Effect of beta blockers on vascular resistance in systemic hypertensionA J Man in 't Veld
British Medical Journal (Clinical Research Ed.)|March 21, 1981
Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implicationsA J Man in 't Veld, M A Schalekamp
Trends in Pharmacological Sciences|July 1, 1991
ACE inhibitors can reverse blood vessel damageP R Saxena, A J Man in 't Veld
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
Endogenous and exogenous agonist regulation of responses to beta-adrenoceptor stimulation in patients with chronic autonomic failureA J Man in 't Veld, M A Schalekamp
European Heart Journal|July 1, 1983
Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertensionA J Man in 't Veld, M A Schalekamp
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Blood Pressure. Supplement|January 1, 1997
Surrogate end points in clinical trialsA J Man in 't Veld
American Heart Journal|December 1, 1990
How to select a drug for the long-term treatment of chronic heart failureA J Man in 't Veld
The American Journal of Cardiology|April 22, 1991
Vasodilation, not cardiodepression, underlies the antihypertensive effect of beta-adrenoceptor antagonistsA J Man in 't Veld
Nederlands Tijdschrift Voor Geneeskunde|November 19, 1983
[Recommendations concerning hypertension by the Public Health Council]A J Man in 't Veld
European Heart Journal|June 1, 1992
Clinical pharmacology, efficacy and safety of a new alpha 1 adrenoceptor antagonist with an additional central action, in hypertensionA J Man in 't Veld
The American Journal of Cardiology|May 15, 1987
Effect of beta blockers on vascular resistance in systemic hypertensionA J Man in 't Veld
British Medical Journal (Clinical Research Ed.)|March 21, 1981
Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implicationsA J Man in 't Veld, M A Schalekamp
Trends in Pharmacological Sciences|July 1, 1991
ACE inhibitors can reverse blood vessel damageP R Saxena, A J Man in 't Veld
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
Endogenous and exogenous agonist regulation of responses to beta-adrenoceptor stimulation in patients with chronic autonomic failureA J Man in 't Veld, M A Schalekamp
European Heart Journal|July 1, 1983
Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertensionA J Man in 't Veld, M A Schalekamp
Pageof 15